EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Biperiden (excluding dosage strength 4mg), ATC N04AA02 for the period 01.09.26 - 31.08.28 (plus extension option 1x12 months)
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Biperiden (ausschl. Wirkstärke 4mg), ATC N04AA02 für die Zeit 01.09.26 - 31.08.28 (zzgl. V.-Option 1x12 Mon)
“Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Biperiden (excluding dosage strength 4mg), ATC N04AA02 for the period 01.09.26 - 31.08.28 (plus extension option 1x12 months)” is a eu-wide public tender. Offers are due by Thursday, 5 July 2029, in 977 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 July 2029, 977 days left, 12:00
- Published
- 17 July 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
DAK-Gesundheit concludes discount agreements for the drug Biperiden.
- Discount agreement for the active ingredient Biperiden, excluding dosage strength 4mg.
- Basic term is from 1 September 2026 to 31 August 2028.
- An extension option of twelve months is possible.
- Pharmaceutical companies can join at any time.
- Offers must be submitted by email, not by post.
Summary made from the German notice and checked against it; the German original is authoritative.
Worth knowing before you bid
The contract runs for 24 months. The notice links the tender documents directly.
Dates of this tender
| Published | Friday, 17 July 2026 |
|---|---|
| Deadline | Thursday, 5 July 2029, 12:00 |
| Tender validity ends (calculated) | Saturday, 4 August 2029 |
Conditions stated in the notice
| Duration | 24 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Service by CPV code
- 33600000 Pharmaceutical products
Questions and answers
How much time is left to bid?
Until Thursday, 5 July 2029, 977 days left. The exact time and how to submit are in the original notice, which is authoritative.
Can a company from another EU country bid?
Yes. This tender is published EU-wide, and above the EU thresholds the EU directives guarantee companies from every member state equal treatment. You submit on the platform named in the notice after registering there.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
In which language are the documents and the offer?
Usually German. The notice states the accepted languages; translations of supporting documents may be requested.
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.